27 min listen
Does the Immune System Matter in Treatment for AML? With Drs. Steven Lane & Sergio Rutella
FromThe Hematologist
Does the Immune System Matter in Treatment for AML? With Drs. Steven Lane & Sergio Rutella
FromThe Hematologist
ratings:
Length:
17 minutes
Released:
Sep 1, 2020
Format:
Podcast episode
Description
In this podcast, Contributing Editor Dr. Steven Lane has a conversation with Dr. Sergio Rutella. They discuss Dr. Lane's Diffusion article from the September/October 2020 issue of The Hematologist, titled, "Does the Immune System Matter in Treatment for AML?" They discuss the role of the immune system in the treatment of acute myeloid leukemia. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/463586/Does-the-Immune-System-Matter-in-Treatment-for-AML.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Sep 1, 2020
Format:
Podcast episode
Titles in the series (100)
BCL-2 Is an Effective Target in Chronic Lymphocytic Leukemia: In her Diffusion article from the May/June issue of The Hematologist, Dr. Ann LaCasce (Dana-Farber Cancer Institute) discusses the use of the recently FDA-approved drug venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL) or sm by The Hematologist